镓-68 FAPI-04 PET/CT 与唾液腺显像诊断原发性干燥综合征的前瞻性比较
该前瞻性研究纳入 21 例疑似原发性干燥综合征(pSS)患者(15 例确诊 pSS,6 例其他自身免疫病对照),比较双时间点 [68Ga]Ga-FAPI-04 PET/CT 与唾液腺显像(SGS)的诊断效能。早期(10 分钟)PET/CT 视觉特异性(66.7% vs. 16.7%)、阳性预测值(87.5% vs. 73.7%)和准确率(85.7% vs. 71.4%)均高于 SGS,敏感性相近(93.3%);半定量 SUVmax 诊断特异性达 100%。
要点
- 早期(10 分钟)[68Ga]Ga-FAPI-04 PET/CT 诊断 pSS 特异性与准确率优于 SGS,敏感性相近。
- 颌下腺与舌下腺 SUVmax 具有显著诊断价值,特异性达 100%。
- 全身 PET/CT 可检出唾液腺外纤维炎性共病,如桥本甲状腺炎、骨关节炎。
核心结论
- [68Ga]Ga-FAPI-04 PET/CT 通过选择性显示活化成纤维细胞,对 pSS 具有良好诊断价值和高特异性,可作为 SGS 的补充工具。
研究设计与样本
- 前瞻性研究,纳入 21 例疑似 pSS 参与者,其中 15 例确诊 pSS、6 例其他自身免疫病非 SS 对照,行双时间点(注射后 10 与 40 分钟)[68Ga]Ga-FAPI-04 PET/CT 并与 SGS 比较。
主要发现
- 早期(10 分钟)PET/CT 视觉特异性 66.7% 高于 SGS 的 16.7%,阳性预测值 87.5% 高于 73.7%,准确率 85.7% 高于 71.4%,敏感性 93.3% 与 SGS 相近。
- 颌下腺与舌下腺 SUVmax 具显著诊断效用(AUC > 0.5,P < 0.05),特异性达 100%,优于受「背景稀释效应」影响的体积参数。
- 早期全身 FAPI 负荷(TLF)与系统性红细胞沉降率(ESR)呈负相关;早期颌下腺 FTV 与 SGS 排泄分数呈正相关(r = 0.594,P = 0.019),腮腺无此相关性。
- 全身 PET/CT 检出偶然的唾液腺外纤维炎性共病,如桥本甲状腺炎、骨关节炎。
关键数值与推荐
- 早期(10 分钟)PET/CT 视觉诊断 pSS:敏感性 93.3%、特异性 66.7%、阳性预测值 87.5%、准确率 85.7%。
- SGS 诊断 pSS:敏感性相近、特异性 16.7%、阳性预测值 73.7%、准确率 71.4%。
- 颌下腺与舌下腺 SUVmax 诊断 pSS 的 AUC > 0.5(P < 0.05),特异性 100%。
- 早期颌下腺 FTV 与 SGS 排泄分数相关:r = 0.594,P = 0.019。
临床怎么用
- 对疑似 pSS 患者,可考虑早期(10 分钟)[68Ga]Ga-FAPI-04 PET/CT 作为 SGS 的补充,以提高诊断特异性并减少假阳性。
- 利用颌下腺与舌下腺 SUVmax 进行半定量评估,可能有助于提高诊断特异性。
- 全身 PET/CT 成像可同时评估唾液腺外纤维炎性共病,支持系统性评估。
局限性
- 样本量小(共 21 例,其中 pSS 15 例、对照 6 例),结论需在大规模多中心前瞻性队列中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary Sjögren's syndrome (pSS) is characterized by progressive fibro-inflammatory glandular injury. While conventional salivary gland scintigraphy (SGS) provides macroscopic functional assessment, it cannot visualize underlying active fibrotic remodeling. This prospective study aimed to evaluate the diagnostic performance of dual-time-point (10 and 40 min post-injection) [68Ga]Ga-FAPI-04 PET/CT-a novel radiotracer targeting activated fibroblasts-compared to SGS in patients with suspected pSS. RESULTS: Among 21 participants (15 with confirmed pSS, 6 non-SS controls with other autoimmune diseases), early-phase (10-minute) PET/CT achieved optimal diagnostic efficacy. Visually, early-phase PET/CT demonstrated substantially higher specificity (66.7% vs. 16.7%), positive predictive value (87.5% vs. 73.7%), and overall accuracy (85.7% vs. 71.4%) compared to SGS, while maintaining comparable high sensitivity (93.3%). Semiquantitatively, the SUVmax of the submandibular and sublingual glands exhibited significant diagnostic utility (AUC > 0.5, P < 0.05), achieving 100% specificity and significantly outperforming volumetric parameters, which were compromised by a "background dilution effect." Clinically, early-phase global FAPI burden (TLF) correlated negatively with the systemic erythrocyte sedimentation rate (ESR). Regionally, early submandibular FTV correlated positively with the SGS excretion fraction (r = 0.594, P = 0.019), whereas the parotid glands exhibited no such correlation, corroborating the asynchronous structural progression of pSS. Furthermore, whole-body PET/CT successfully detected incidental extra-salivary fibro-inflammatory comorbidities (e.g., Hashimoto's thyroiditis, osteoarthritis). CONCLUSIONS: [68Ga]Ga-FAPI-04 PET/CT demonstrates promising diagnostic utility and high specificity for pSS by selectively visualizing active fibroblast activation. It elegantly complements the macroscopic functional evaluation of SGS while providing profound in vivo insights into asynchronous disease progression. Crucially, its whole-body imaging capability delivers unparalleled clinical value for mapping systemic, multi-organ comorbidities. These findings underscore its potential as an advanced adjunctive diagnostic tool, warranting rigorous validation in large-scale, multicenter prospective cohorts.
引用
- Cheng K, Xu T, Li Z, et al. Prospective comparison of [68Ga]Ga-FAPI-04 PET/CT and salivary gland scintigraphy for the diagnosis of primary Sjögren's syndrome. EJNMMI Res. 2026. PMID: 42084666. doi:10.1186/s13550-026-01438-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。